Our results demonstrated that chloroquine synergistically enhanced the chemosensitivity of glioma cells toward NTZ by the inhibition of ING1 autophagic degradation, which suggests a novel therapeutic strategy for clinical treatment of glioma. This evidence concerns the gene ING1 and central nervous system cancer.